ELIANA BARRIOCANAL CASADO-rekin lankidetzan egindako argitalpenak (6)

2021

  1. β-RA Targets Mitochondrial Metabolism and Adipogenesis, Leading to Therapeutic Benefits against CoQ Deficiency and Age-Related Overweight

    Biomedicines, Vol. 9, Núm. 10

2019

  1. β-RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in Coq9 R239X mice

    EMBO Molecular Medicine, Vol. 11, Núm. 1

  2. Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease

    EBioMedicine, Vol. 42, pp. 511-523

2018

  1. Reduction in the levels of CoQ biosynthetic proteins is related to an increase in lifespan without evidence of hepatic mitohormesis

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome

    EMBO Molecular Medicine, Vol. 9, Núm. 1, pp. 78-95

  2. Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases

    PLoS ONE, Vol. 12, Núm. 8